ArticleScientific reports2020

Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models.

Naoto Kunimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.